SAB Biotherapeutics Inc. (SABS:NASDAQ) shot up at $0.8, a gain of 28.5%. On Thu, Oct 19, 2023, SABS:NASDAQ touched a New 2-Week High of $0.8. The stock appeared on our News Catalysts scanner on Thu, Oct 19, 2023 at 10:32 AM in the 'BIOTECH' category. From Thu, Oct 05, 2023, the stock recorded 40.00% Up Days and 45.45% Green Days
The stock spiked on Thu, May 04, 2023 at $1.19 with a volume of 9M+.
About SAB Biotherapeutics Inc. (SABS:NASDAQ)
SAB Biotherapeutics Inc is a clinical-stage biopharmaceutical company advancing a class of immunotherapies based on its human polyclonal antibodies.
Top 10 Gainers:
- LMP Automotive Holdings, Inc. (LMPX:NASDAQ), 71.43%
- SeaStar Medical Inc Com (ICU:NASDAQ), 54.35%
- Mmtec, Inc. (MTC:NASDAQ), 51.47%
- Outlook Therapeutics, Inc. (OTLK:NASDAQ), 39.92%
- Spectral AI Inc. (MDAI:NASDAQ), 39.38%
- Atreca, Inc. (BCEL:NASDAQ), 35.87%
- XORTX Therapeutics Inc. (XRTX:NASDAQ), 34.23%
- SAB Biotherapeutics Inc. (SABS:NASDAQ), 28.53%
- Mangoceuticals Inc. (MGRX:NASDAQ), 27.04%
- Hub Cyber Security Ltd. (HUBC:NASDAQ), 24.89%